US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

32.15

+0.85392.73%

Volume:2K

Turnover:76.26K

Market Cap:52.21M

PE:- -

High:32.15

Open:31.76

Low:31.76

Close:31.30

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:1.74

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)

Cytek Owes Beckman Coulter $56 Mln in Cell-Analysis Patent Case, US Jury Says

William O'Neil Initiates Thermo Fisher Scientific at Buy

MT Newswires Live

Revvity Inc. Stock Advances 3.9%, Outperforms Peers

Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million

Danaher Unit IDT Expands DNA Synthesis Capabilities to Support High-Diversity Assays

Thermo Fisher Scientific (TMO) Climbed, So What Is Behind The Fresh Attention?

Simply Wall St.

Steris PLC Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Danaher Corp Stock (DHR) Closed Up by 6.16% on Aug 19: A Full Analysis

Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.67% on Aug 19: Facts Behind the Movement

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

Insider Move At Lifestance Health Group Sparks Investor Attention

Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says

MT Newswires Live

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live

Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says

MT Newswires Live

Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00

THOMSON REUTERS

Argenx price target raised to $1,150 from $1,050 at Wedbush

10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance

Simply Wall St.

Argenx Se (ARGX) Receives a Buy from Citi

Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/FMED/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":32.15,"timestamp":1789656210653,"preClose":31.2961,"halted":0,"volume":2389,"delay":0,"changeRate":0.02728454983208769,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Trading","change":0.8539,"latestTime":"09-17 10:56:45 EDT","open":31.76,"high":32.15,"low":31.76,"amount":76262.20747,"amplitude":0.012462,"askPrice":32.14,"askSize":500,"bidPrice":32.08,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":31.2961,"sharesOutstanding":2323806,"nav":31.3164,"aum":50851758.2184,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":31.27,"preClose":31.2961,"latestTime":"19:30 EDT","volume":9,"amount":281.6649,"timestamp":1789601404804,"change":-0.0261,"changeRate":-0.000834,"amplitude":0},"volumeRatio":1.742655,"impliedVol":0.0666,"impliedVolPercentile":0.0055},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.742655,"shares":1623806,"dividePrice":0,"high":32.15,"amplitude":0.012462,"preClose":31.2961,"low":31.76,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":32.15,"committee":-0.666667,"eps":0,"divideRate":0,"volume":2389,"delay":0,"ttmEps":0,"open":31.76,"prevYearClose":27.05,"prevWeekClose":31,"prevMonthClose":31.775,"prevQuarterClose":28.525,"fiveDayClose":30.8414,"twentyDayClose":32.8877,"sixtyDayClose":26.3894},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661784220","title":"Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661784220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661784220?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:20","pubTimestamp":1787566808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Enliven Therapeutics (ELVN), Argenx Se (ARGX) and Aq...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-enliven-therapeutics-elvn-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-enliven-therapeutics-elvn-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TBXU","LU0320765992.SGD","LU2324357040.USD","ARGX","FMED","IE00BJJMRZ35.SGD","BK4505","IE0034235188.USD","BK4139","IE0009355771.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU1983260115.SGD","BK4588","IE00BJT1NW94.SGD","BK4007","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4585","LU0109394709.USD","ELVN","IE00B2B36J28.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661546290","title":"Cytek Owes Beckman Coulter $56 Mln in Cell-Analysis Patent Case, US Jury Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2661546290","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661546290?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:02","pubTimestamp":1787346151,"startTime":"0","endTime":"0","summary":"UPDATE 1-Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury saysAug 21 (Reuters)-A Delaware federal jury determined on Friday that Cytek Biosciences'CTKB.Oproducts for analyzing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL6N44I12W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","LU2125909593.SGD","DHR","LU1551013342.USD","LU1923622614.USD","SGXZ57979304.SGD","LU0175139822.USD","IE00BQXX3C00.GBP","IE00BQXX3F31.USD","LU0432979614.USD","IE00BQXX3D17.EUR","LU2265009873.SGD","LU1057294990.SGD","CTKB","LU0097036916.USD","LU0320765059.SGD","LU2355687059.USD","LU1551013425.SGD","LU0157215616.USD","LU0708995401.HKD","BK4504","LU0528227936.USD","LU1023059063.AUD","LU1366333091.USD","LU1974910355.USD","LU1791710400.SGD","LU2244417387.USD","IE000M9KFDE8.USD","LU0109391861.USD","LU2063271972.USD","LU2112291526.USD","LU2125909247.SGD","BK4588","LU0289960550.SGD","LU2211814178.USD","LU0882574055.USD","LU2023250504.SGD","LU1804176565.USD","BK4581","LU0289961442.SGD","LU0390134368.USD","LU0820561909.HKD","LU1791710582.SGD","FMED","LU1917777945.USD","LU0672654240.SGD","LU0107464264.USD","IE00BZ1G4Q59.USD","LU0312595415.SGD","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661266450","title":"William O'Neil Initiates Thermo Fisher Scientific at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661266450","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661266450?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:18","pubTimestamp":1787303883,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific (TMO) has an average rating of buy and mean price target of $643.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2092937221.SGD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4535","LU1023059063.AUD","LU0128525929.USD","LU2357305700.SGD","BK4534","LU0557290698.USD","GNMX","HRTS","LU1720051017.SGD","LU0823416689.USD","LU1815333072.USD","LU0061474960.USD","LU0708994859.HKD","IE00B19Z8W00.USD","LU1712237335.SGD","FMED","LU1548497426.USD","TMED","LU2764263203.CNY","IE00B1BXHZ80.USD","LU1983299246.USD","LU1057294990.SGD","BK4533","LU2041044095.USD","LU1633808545.USD","LU0029864427.USD","LU1720051108.HKD","LU0011850046.USD","LU1791710582.SGD","LU2125909916.SGD","LU2125909247.SGD","LU2089984988.USD","LU2125910336.SGD","LU1791710400.SGD","LU0310800379.SGD","LU0342679015.USD","BK4121","LU0528227936.USD","TMO","LU1280957306.USD","IE00B19Z9505.USD","BK4588","LU1291159041.SGD","IE00BQXX3D17.EUR","LU1923621640.USD","LU0316494557.USD","LU1803068623.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661322172","title":"Revvity Inc. Stock Advances 3.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661322172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661322172?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Revvity Inc. rallied 3.9% to $124.13 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.9% to 7,641.16 and Dow Jones Industrial Average falling 1.3% to 52,759.21.This was the stock's second consecutive day of gains.Revvity Inc. hit a new 52-week high, surpassing its previous peak of $122.11, which the company achieved on August 19th.The stock outperformed some of its peers, as Danaher Corp. rose 2.1% to $215.91, IDEXX Laboratories Inc. fell 2.9% to $545.86, and Agilent Technologies Inc. rose 0.57% to $156.30.Trading volume totaled 2.3 million, compared to the 50-day average of 1.5 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710400.SGD","LU1057294990.SGD","LU0175139822.USD","RVTY","IE00BKVL7J92.USD","LU0097036916.USD","LU1974910355.USD","LU1551013425.SGD","LU0289960550.SGD","LU0347712357.USD","LU1917777945.USD","LU2063271972.USD","IDXX","LU1941712348.USD","LU0109391861.USD","GB00B4QBRK32.GBP","LU2404859741.USD","LU0289961442.SGD","LU0672654240.SGD","LU1061106388.HKD","LU1941712264.USD","LU2125909247.SGD","BK4585","LU0289739343.SGD","A","IE00BN0W2W23.USD","SG9999013999.USD","LU1804176565.USD","IE00BLDYK493.USD","LU2112291526.USD","BK4504","IE00BN0W2T93.GBP","LU2125910336.SGD","FMED","LU2229751404.USD","LU2089279066.USD","BK4581","LU1165135440.EUR","DHR","BK4082","LU0157215616.USD","BK4121","LU0820561818.USD","SGXZ23171101.USD","PAWZ","LU2041044095.USD","LU2355687059.USD","BK4567","LU1791710582.SGD","LU1923621640.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661234283","title":"Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661234283","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661234283?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:03","pubTimestamp":1787256208,"startTime":"0","endTime":"0","summary":"Thermo Fisher CHRO Lisa P. Britt disposes of 11,440 common shares worth $7.01 millionLisa P. Britt, Sr. VP and Chief HR Officer, sold 11,440 Thermo Fisher shares on Aug. 19, 2026 at USD 613.12.Transac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLVzrkP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Thermo Fisher CHRO Lisa P. Britt Disposes of 11,440 Common Shares Worth $7.01 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1720051017.SGD","BK4548","LU0342679015.USD","IE00BQXX3C00.GBP","FMED","LU1023059063.AUD","LU0957791311.USD","LU2125909916.SGD","LU2125909759.SGD","LU0310800379.SGD","LU1064131342.USD","LU1989771016.USD","LU1854104046.USD","LU1633808545.USD","LU2468319806.SGD","LU2433249047.HKD","LU0316494557.USD","IE00BKPKM429.USD","HRTS","IE00BJT1NW94.SGD","IE0009355771.USD","LU2125909593.SGD","LU0823416689.USD","IE00B19Z9505.USD","LU2125910179.SGD","LU1803068623.USD","BK4588","LU1670627923.USD","LU1988902786.USD","LU0128525929.USD","LU2063271972.USD","LU2089984988.USD","LU2543165471.USD","LU1548497426.USD","GNMX","LU1267930573.SGD","IE00BQXX3D17.EUR","LU2764262908.HKD","LU1983299246.USD","LU0070302665.USD","BK4585","LU2720916845.USD","LU2360108059.USD","LU1623119135.USD","TMO","TMED","LU1791710400.SGD","LU0266013472.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660826442","title":"Danaher Unit IDT Expands DNA Synthesis Capabilities to Support High-Diversity Assays","url":"https://stock-news.laohu8.com/highlight/detail?id=2660826442","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660826442?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:55","pubTimestamp":1787230539,"startTime":"0","endTime":"0","summary":"Danaher unit IDT expands DNA synthesis capabilities to support high-diversity assaysDanaher unit Integrated DNA Technologies expanded DNA synthesis capabilities to cover higher-diversity designs, larg","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL4Z6bb5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930730.SGD","IE00BQXX3D17.EUR","IE00BZ1G4Q59.USD","DHR","LU0312595415.SGD","IE00BQXX3F31.USD","BK4504","BK4121","LU2023250504.SGD","LU1061106388.HKD","BK4581","LU0187121727.USD","LU0109391861.USD","LU0390134368.USD","LU0528227936.USD","LU0672654240.SGD","LU0320765059.SGD","FMED","LU2125910336.SGD","LU0820561909.HKD","LU2244417387.USD","LU0114720955.EUR","LU1974910355.USD","LU2112291526.USD","LU2125909247.SGD","LU1791710582.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00BKVL7J92.USD","LU0097036916.USD","LU0157215616.USD","LU1917777945.USD","LU0943347566.SGD","LU1804176565.USD","LU0107464264.USD","BK4533","LU1023059063.AUD","SG9999013999.USD","LU2355687059.USD","LU0432979614.USD","LU1923622614.USD","LU1551013425.SGD","BK4588","IE0004445239.USD","LU1791710400.SGD","SG9999001176.USD","LU0289960550.SGD","LU0122379950.USD","LU2265009873.SGD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660834352","title":"Thermo Fisher Scientific (TMO) Climbed, So What Is Behind The Fresh Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660834352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660834352?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:32","pubTimestamp":1787214754,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific (TMO) drew fresh attention after reporting quarterly revenue and earnings that exceeded analyst expectations, alongside completing a large Parkinson's proteomics project with The Michael J. Fox Foundation.\nSee our latest analysis for Thermo Fisher Scientific.\nThermo Fisher Scientific's recent earnings beat and the completion of the Parkinson's proteomics project have coincided with strong momentum, including a 16.6% 30 day share price return and a 24.5% 1 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/97023-main-header/1756189961534","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/97023-main-header/1756189961534"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-scientific-tmo-climbed-so-what-is-behind-the-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-scientific-tmo-climbed-so-what-is-behind-the-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","LU0345770308.USD","LU2125910336.SGD","TMO","LU1923621640.USD","LU1791710582.SGD","LU1670628061.USD","LU0708994859.HKD","LU1023059063.AUD","LU2125909593.SGD","LU2298321311.HKD","BK4585","LU0432979614.USD","LU1983299246.USD","LU2764262908.HKD","LU2720916845.USD","IE0034235188.USD","IE00BFTCPJ56.SGD","FMED","LU2764263203.CNY","LU0320765489.SGD","IE00B19Z8X17.USD","LU2543165471.USD","LU1923622614.USD","TMED","LU0070302665.USD","LU1815333072.USD","LU1989771016.USD","LU2764263039.SGD","LU2092937221.SGD","LU2125909916.SGD","LU2360108059.USD","IE00B19Z9505.USD","BK4566","LU0096362180.USD","LU2125909247.SGD","LU0128525929.USD","IE00BJJMRZ35.SGD","LU2125909759.SGD","BK4548","LU0345770993.USD","LU1670627923.USD","BK4533","HRTS","GNMX","LU0882574055.USD","LU2089984988.USD","GB00BDT5M118.USD","IE00BQXX3F31.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660756114","title":"Steris PLC Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2660756114","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660756114?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:04","pubTimestamp":1787173440,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  advanced 1.95% to $236.91 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.21% to 7,707.98 and the Dow Jones Industrial Average  rising 0.22% to 53,463.05.This was the stock's second consecutive day of gains.Steris PLC closed 12.07% below its 52-week high of $269.44, which the company reached on January 16th.The stock underperformed when compared to some of its competitors Wednesday, as Thermo Fisher Scientific Inc.  rose 4.16% to $613.54, Danaher Corp.  rose 5.97% to $211.50, and Becton Dickinson & Co.  rose 3.78% to $187.60.Trading volume  remained 84,827 below its 50-day average volume of 791,095.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU0289739343.SGD","BK4581","HRTS","LU1201861165.SGD","LU2265009873.SGD","LU1548497426.USD","LU2125909593.SGD","LU1057294990.SGD","LU0943347566.SGD","LU1712237335.SGD","LU2764263039.SGD","LU0433182093.SGD","BK4535","BK4548","LU1150488135.SGD","LU1489326972.SGD","LU0528227936.USD","LU1023059063.AUD","LU1633808545.USD","LU0342679015.USD","LU0878866978.SGD","LU1983299246.USD","LU2433249047.HKD","LU0345770308.USD","DHR","FMED","IE00B19Z8X17.USD","LU2125910336.SGD","IE00BFTCPJ56.SGD","LU0985320562.USD","LU2211815571.USD","IE00B19Z8W00.USD","BDX","TMED","LU0130103400.USD","LU0708995401.HKD","LU2298321311.HKD","IE00BKVL7J92.USD","STE","GNMX","LU2355687059.USD","TMO","IHI","LU0208291251.USD","LU1551013425.SGD","BK4588","LU0477156797.USD","LU0648000940.SGD","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473613","title":"Danaher Corp Stock (DHR) Closed Up by 6.16% on Aug 19: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473613","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473613?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:15","pubTimestamp":1787170543,"startTime":"0","endTime":"0","summary":"• Danaher reported second-quarter revenue and adjusted earnings exceeding Wall Street consensus estimates.\n• Julie Sawyer Montgomery was appointed as the new chief executive officer.\n• Danaher generated $24.57B in annual revenue with $3.61B in net profit.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262119120-market-movers-dhr-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DHR","FMED","BK4534","LU2125909247.SGD","LU1061106388.HKD","LU0107464264.USD","LU2125910179.SGD","LU2211814178.USD","LU0114720955.EUR","LU1551013425.SGD","LU1551013342.USD","LU0689472784.USD","LU1804176565.USD","LU0157215616.USD","LU0708995401.HKD","LU0122379950.USD","BK4585","LU0820561909.HKD","LU0109391861.USD","LU0882574055.USD","BK4121","LU2265009873.SGD","LU0187121727.USD","LU0390134368.USD","SGXZ57979304.SGD","LU1923622614.USD","LU0672654240.SGD","LU1917777945.USD","SG9999013999.USD","LU2023250504.SGD","LU2125909593.SGD","LU1791710400.SGD","LU0289960550.SGD","LU1923621640.USD","LU0528227936.USD","BK4588","IE00BQXX3F31.USD","LU2125910336.SGD","IE000M9KFDE8.USD","SGXZ23171101.USD","LU2106854487.HKD","LU0511384066.AUD","LU1023059063.AUD","LU1057294990.SGD","LU1366333091.USD","SG9999001176.SGD","LU0432979614.USD","LU0097036916.USD","LU1974910355.USD","LU2355687059.USD","LU0289961442.SGD","LU0943347566.SGD","LU0320765059.SGD","BK4581","LU2244417387.USD","LU0312595415.SGD","IE00BQXX3D17.EUR","LU0175139822.USD","LU0289739343.SGD","IE00BQXX3C00.GBP","LU0820561818.USD","BK4533","IE0004445239.USD","LU2063271972.USD","LU1791710582.SGD","SG9999001176.USD","SG9999004303.SGD","LU0820562030.AUD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1267930730.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427589","title":"Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.67% on Aug 19: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427589","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427589?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:15","pubTimestamp":1787159744,"startTime":"0","endTime":"0","summary":"• Thermo Fisher raised its full-year outlook following strong second-quarter financial results.\n• The company sold its microbiology business to Astorg for over one billion dollars.\n• Institutional managers and hedge funds recently built fresh positions in the company.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118659-market-movers-tmo-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0708994859.HKD","LU2211815571.USD","IE00B19Z8X17.USD","LU0208291251.USD","LU1023059063.AUD","LU1923621640.USD","TMED","IE00B4R5TH58.HKD","LU1623119135.USD","LU1548497426.USD","LU1791710400.SGD","LU2211814178.USD","FMED","LU1153585028.USD","LU2433249047.HKD","LU1064131342.USD","IE00BJT1NW94.SGD","BK4566","LU1633808545.USD","LU2125909247.SGD","HRTS","LU2041044095.USD","LU1923622614.USD","LU1815333072.USD","LU2125910336.SGD","IE00B19Z8W00.USD","LU2125909593.SGD","LU0316494557.USD","GNMX","LU2357305700.SGD","LU1983299246.USD","LU0234572021.USD","LU1803068623.USD","BK4121","BK4535","LU0882574055.USD","LU2125909916.SGD","LU0070302665.USD","LU0114720955.EUR","LU1291159041.SGD","IE00B19Z9505.USD","BK4585","LU1989771016.USD","LU2092937221.SGD","LU2063271972.USD","BK4588","LU0266013472.USD","LU1854104046.USD","IE00BKPKM429.USD","LU1923622291.USD","LU1712237335.SGD","IE00B2B36J28.USD","LU2764263039.SGD","IE00BQXX3F31.USD","IE00B1BXHZ80.USD","IE0034235188.USD","LU0640476718.USD","LU2125910179.SGD","LU0342679015.USD","LU2764263203.CNY","LU2543165471.USD","LU0345770993.USD","LU1670628061.USD","LU1280957306.USD","LU2264538146.SGD","LU2089984988.USD","IE0002141913.USD","LU0345770308.USD","IE00BQXX3C00.GBP","LU0557290698.USD","LU0310800379.SGD","LU1267930573.SGD","LU0011850046.USD","LU1791710582.SGD","LU1988902786.USD","LU1720051017.SGD","LU1057294990.SGD","LU0957791311.USD","LU2360108059.USD","LU0096362180.USD","LU0122379950.USD","LU2468319806.SGD","GB00BDT5M118.USD","BK4581","LU1061106388.HKD","LU1854103824.USD","LU0029864427.USD","LU0320765489.SGD","LU2298321311.HKD","LU2125909759.SGD","BK4548","BK4533","LU1720051108.HKD","LU1670627923.USD","LU0528227936.USD","LU0432979614.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4534","TMO","IE00BQXX3D17.EUR","LU2112291526.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0061474960.USD","LU2764262908.HKD","LU2720916845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421716","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421716","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421716?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:18","pubTimestamp":1787152727,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.68% to 1,973.64 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm BioNTech  and biopharmaceutical company Grifols , which advanced 24% and 5.6% respectively. They were followed by semiconductor company Sequans Communications  and biopharmaceutical company argenx , which rose 3.3% and 3% respectively.The decliners from continental Europe were led by internet browser company Opera  and biotech firm Evaxion , which fell 7.9% and 6% respectively. They were followed by accommodations booking site Trivago  and telecommunications company Nokia , which were down 4.3% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and mining company BHP Group , which increased 9.2% and 4.5% respectively. They were followed by software firm Endava  and biopharmaceutical company Bicycle Therapeutics , w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVIB","IE00BJJMRZ35.SGD","IE0009355771.USD","LNOK","BK4547","BK4585","OPRA","SNN","LU0109394709.USD","SLX","LU0823416689.USD","TRVG","LU0300736062.USD","AFG","FMED","GRFS","IBB","IE00B4R5TH58.HKD","BK4548","IE00BMPRXN33.USD","IEUR","IE00B2B36J28.USD","ARGX","IE00BJT1NW94.SGD","TRIB","LFGY","LU1983260115.SGD","BK4117","TBXU","NOK","DAVA.AU","LU0648005311.SGD","BHP.AU","COAL","LU0006061336.USD","EPV","BDRX","LU0889565916.HKD","PUK","BNTX","SQNS","AUTL","EVAX","DAVA","BK4141","BK4588","XBIX","LU2324357040.USD","BCYC","BHP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660249416","title":"Insider Move At Lifestance Health Group Sparks Investor Attention","url":"https://stock-news.laohu8.com/highlight/detail?id=2660249416","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660249416?lang=en_us&edition=fundamental","pubTime":"2026-08-19 10:09","pubTimestamp":1787105395,"startTime":"0","endTime":"0","summary":"New insider activity at Lifestance Health Group ( ($LFST) ) has taken place on August 18, 2026. Director Teresa DeLuca of Lifestance Health Group h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-move-at-lifestance-health-group-sparks-investor-attention-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-move-at-lifestance-health-group-sparks-investor-attention-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4539","BK4196","LFST","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495742","title":"Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495742","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495742?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:35","pubTimestamp":1787067344,"startTime":"0","endTime":"0","summary":"Argenx's  phase 3 data on Vyvgart reduce the uncertainty around its potential $1.5 billion to $2 billion autoimmune myositis opportunity, Oppenheimer said.The phase 3 study of Vyvgart achieved its primary endpoint for the combined dermatomyositis and immune-mediated necrotizing myopathy, or IMNM, population, the investment firm said in a Monday note, noting IMNM as the therapy's \"most derisked\" path to approval.In the IMNM subgroup, Vyvgart-treated patients showed a 14.8-point greater improvement in mean Total Improvement Score versus placebo at week 52, a statistically significant result with a p-value of 0.0048, Oppenheimer added.The results are a testament to the company's pipeline-in-a-product strategy, bringing it closer to entering rheumatology as a second therapeutic category, according to the noteOppenheimer raised its price target on argenx to $1,100 from $1,037, while keeping its outperform outlook.Shares of Argenx were up 1.1% in Tuesday trading.Price: 998.83, Change: +10.99","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","LU1983260115.SGD","FMED","BK4505","BK4139","OPY","BK4585","TBXU","BK4127","BK4588","IBB","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE0002141913.USD","ARGX","LU0109394709.USD","IE0034235188.USD","LU2324357040.USD","IE00B2B36J28.USD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0823416689.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495503","title":"Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495503","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495503?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:06","pubTimestamp":1787065592,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) Vyvgart Hytrulo is likely to get approval from the US Food and Drug Administration for adults with immune-mediated necrotizing myopathy and dermatomyositis, RBC Capital Markets analyst","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0009355771.USD","LU0823416689.USD","FMED","LU0109394709.USD","BK4585","IE00BJJMRZ35.SGD","LABU","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4139","IE0002141913.USD","IE0034235188.USD","IE00B4R5TH58.HKD","BK4588","BK4505","ARGX","IBB","LU2324357040.USD","LU0320765992.SGD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660070493","title":"Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660070493","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660070493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:54","pubTimestamp":1787064888,"startTime":"0","endTime":"0","summary":"Argenx's (ARGX) latest myositis data strengthened the outlook for efgartigimod, particularly in immune-mediated necrotizing myopathy, resulting in higher probability-of-success assumptions, Morgan Sta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","ARGX","IE00B4R5TH58.HKD","IMNM","BK4588","BK4563","BK4139","LU0889565916.HKD","BK4505","IE00BJJMRZ35.SGD","LU0823416689.USD","LU1983260115.SGD","IE0034235188.USD","TBXU","LU0109394709.USD","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","FMED","IE00B2B36J28.USD","IE0002141913.USD","IE0009355771.USD","LU0320765992.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660646056","title":"Argenx Se : Morgan Stanley Raises Target Price to $1230.00 from $1200.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2660646056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660646056?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:12","pubTimestamp":1787058744,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nAZN4TEZHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","IE00BJT1NW94.SGD","BK4505","FMED","IE0009355771.USD","LU2324357040.USD","LU0823416689.USD","IE0034235188.USD","IBB","LU0320765992.SGD","ARGX","TBXU","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU1983260115.SGD","LU0889565916.HKD","BK4139","BK4585","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660462876","title":"Argenx price target raised to $1,150 from $1,050 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2660462876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660462876?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:50","pubTimestamp":1787053809,"startTime":"0","endTime":"0","summary":"Wedbush raised the firm’s price target on Argenx (ARGX) to $1,150 from $1,050 and keeps an Outperform rating on the shares. The firm notes the comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1150-from-1050-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1150-from-1050-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","IBB","BK4505","BK4588","IE0002141913.USD","BK4585","BK4139","IE00BJT1NW94.SGD","TBXU","LU0823416689.USD","LU0109394709.USD","LU1983260115.SGD","FMED","IE00B4R5TH58.HKD","LU0889565916.HKD","ARGX","IE00B2B36J28.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0034235188.USD","LU2324357040.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660469194","title":"10x Genomics (TXG) Stock Looks Fully Priced As Atera Demand Lifts Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469194?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:25","pubTimestamp":1787045146,"startTime":"0","endTime":"0","summary":"10x Genomics stock has delivered a very strong 330.8% return over the past year, yet the current valuation checks lean expensive rather than pointing to an obvious bargain.\n\nThe 330.8% gain over 12 months highlights how quickly expectations have shifted for 10x Genomics, which raises the bar for what the business now needs to deliver.\nStronger interest in the Atera spatial biology platform and related partnerships can support higher revenue expectations, while any slowdown in that demand or...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-fully-priced-as-atera-demand-li","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txg/10x-genomics/news/10x-genomics-txg-stock-looks-fully-priced-as-atera-demand-li","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARKG","FMED","BK4121","BK4585","BK4588","LU1861558580.USD","TXG","LU0963586101.USD","BK4548","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457633","title":"Argenx Se (ARGX) Receives a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660457633?lang=en_us&edition=fundamental","pubTime":"2026-08-18 14:55","pubTimestamp":1787036118,"startTime":"0","endTime":"0","summary":"In a report released today, Samantha Semenkow from Citi maintained a Buy rating on Argenx Se, with a price target of $1,301.00. According to TipRan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/argenx-se-argx-receives-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823416689.USD","IE00B2B36J28.USD","BK4505","LU2324357040.USD","BK4585","IE0009355771.USD","IBB","IE00BJJMRZ35.SGD","FMED","BK4139","BK4588","ARGX","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","LU0109394709.USD","LU1983260115.SGD","IE00BFTCPJ56.SGD","TBXU","IE0034235188.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660452322","title":"Why LifeStance Health Group (LFST) Is Up 5.5% After Profitable Quarter, Higher Guidance And New Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660452322","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660452322?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:21","pubTimestamp":1787030492,"startTime":"0","endTime":"0","summary":"In the second quarter of 2026, LifeStance Health Group, Inc. reported revenue of US$435.35 million and net income of US$23.61 million, turned around from a net loss a year earlier, and completed a US$97.19 million share repurchase program under its February 2026 authorization while also announcing a new up to US$100 million buyback.\nThe company also raised its full-year 2026 revenue outlook to a range of US$1.69 billion to US$1.73 billion, signaling management’s confidence alongside this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lfst/lifestance-health-group/news/why-lifestance-health-group-lfst-is-up-55-after-profitable-q","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LFST","AIPO","BK4539","BK4196","BK4535","FMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}